ArticlePLoS computational biology2025
Deep learning approach for automatic assessment of schizophrenia and bipolar disorder in patients using R-R intervals.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From Reactive to Proactive Healthcare: Synergizing Wearable Biomarkers and Machine Learning in Digital Therapeutics.Bioengineering (Basel, Switzerland) · 2026Review
- Artificial Intelligence in the Assessment of Heart Rate Variability as an Instrument to Understand the Connection Between Psychologic and Psychiatric Conditions and the Heart.Bioengineering (Basel, Switzerland) · 2026Review
- Support vector machine algorithm-based wearable device in sports rehabilitation training for people with disabilities.Scientific reports · 2026Article
- An interpretable XAI deep EEG model for schizophrenia diagnosis using feature selection and attention mechanisms.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Schizophrenia and bipolar disorder are severe mental illnesses that significantly impact quality of life. These disorders are associated with autonomic nervous system dysfunction, which can be assessed through heart activity analysis. Heart rate variability (HRV) has shown promise as a potential biomarker for diagnostic support and early screening of those conditions. This study aims to develop and evaluate an automated classification method for schizophrenia and bipolar disorder using short-duration electrocardiogram (ECG) signals recorded with a low-cost wearable device. We conducted classification experiments using machine learning techniques to analyze R-R interval windows extracted from short ECG recordings. The study included 60 participants-30 individuals diagnosed with schizophrenia or bipolar disorder and 30 control subjects. We evaluated multiple machine learning models, including Support Vector Machines, XGBoost, multilayer perceptrons, Gated Recurrent Units, and ensemble methods. Two time window lengths (about 1 and 5 minutes) were evaluated. Performance was assessed using 5-fold cross-validation and leave-one-out cross-validation, with hyperparameter optimization and patient-level classification based on individual window decisions. Our method achieved classification accuracy of 83% for the 5-fold cross-validation and 80% for the leave-one-out scenario. Despite the complexity of our scenario, which mirrors real-world clinical settings, the proposed approach yielded performance comparable to advanced diagnostic methods reported in the literature. The results highlight the potential of short-duration HRV analysis as a cost-effective and accessible tool for aiding in the diagnosis of schizophrenia and bipolar disorder. Our findings support the feasibility of using wearable ECG devices and machine learning-based classification for psychiatric screening, paving the way for further research and clinical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.